Internal Medicine, Gastroenterology · Cleveland, OH
NPI
1669725057
Since 2012
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
2500 Metrohealth Dr
Cleveland, OH, 44109
Phone (216) 778-7800
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
841 services
Medicare patients, 2024
475
Average age 73
Drug cost, 2024
$844K
1,227 prescriptions
Company payments, 2025
$108K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Imad Asaad was code 45385 (colonoscopy - lesion removal), 124 times for 122 patients. In total Imad Asaad billed 841 services in 36 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 124 | 122 | $195.97 | $24K |
| 43239 Upper GI Endoscopy | Facility | 95 | 91 | $66.41 | $6,309 |
| 99214 Office E&M - Established | Office | 94 | 74 | $91.06 | $8,560 |
| 45380 Lower GI Endoscopy - Other | Facility | 93 | 92 | $92.46 | $8,599 |
| 99204 Office E&M - New | Office | 54 | 54 | $117.07 | $6,322 |
| 99222 Hospital E&M - Initial | Facility | 51 | 47 | $96.95 | $4,945 |
| 99213 Office E&M - Established | Office | 43 | 42 | $61.42 | $2,641 |
| 99203 Office E&M - New | Office | 32 | 32 | $62.65 | $2,005 |
| 91200 Standard X-ray | Facility | 29 | 29 | $7.64 | $222 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 27 | 26 | $169.59 | $4,579 |
| 99221 Hospital E&M - Initial | Facility | 26 | 26 | $60.16 | $1,564 |
| 43249 Upper GI Endoscopy | Facility | 25 | 23 | $94.19 | $2,355 |
| 45381 Lower GI Endoscopy - Other | Facility | 22 | 22 | $11.95 | $263 |
| 43235 Upper GI Endoscopy | Facility | 19 | 18 | $75.82 | $1,441 |
| 45378 Lower GI Endoscopy - Other | Facility | 17 | 17 | $121.86 | $2,072 |
By year: 2022 $42K for 537 services; 2023 $115K for 1,059 services; 2024 $86K for 841 services.
Medicare prescription drug claims, 2024
In 2024, the drug Imad Asaad prescribed most often to Medicare patients was Omeprazole, with 249 prescriptions and refills. In total Imad Asaad wrote 1,227 Medicare prescriptions that cost $844K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 249 | 433 | 90 | $2,294 |
| Pantoprazole Sodium Generic | 240 | 460 | 89 | $3,135 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 87 | 87 | 85 | $15K |
| Dicyclomine Hcl Generic | 48 | 66 | 17 | $732 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 37 | 37 | 35 | $455 |
| Zenpep Lipase/Protease/Amylase | 35 | 49 | Under 11 | $77K |
| Creon Lipase/Protease/Amylase | 31 | 43 | Under 11 | $90K |
| Esomeprazole Magnesium Generic | 27 | 45 | Under 11 | $1,803 |
| Pancreaze Lipase/Protease/Amylase | 26 | 27 | Under 11 | $60K |
| Mesalamine Generic | 26 | 50 | Under 11 | $19K |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 26 | 26 | 26 | $3,591 |
| Loperamide Loperamide Hcl | 25 | 33 | Under 11 | $586 |
| Cholestyramine Cholestyramine (With Sugar) | 24 | 33 | Under 11 | $1,353 |
| Carvedilol Generic | 24 | 48 | Under 11 | $287 |
| Ursodiol Generic | 21 | 41 | Under 11 | $5,788 |
Brand drugs: - claims; generic drugs: 922 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Imad Asaad $108K ($108K in general payments such as food, travel and fees) from 17 companies. The largest payer was Madrigal Pharmaceuticals with $62K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 43 | $62K |
| Novo Nordisk Inc NVO | 15 | $31K |
| Gilead Sciences, Inc. GILD | 29 | $12K |
| Abbvie Inc. ABBV | 36 | $624 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $225 |
| Genzyme Corporation SNY | 8 | $137 |
| Aimmune Therapeutics, Inc. | 4 | $80.47 |
| Lilly USA, LLC LLY | 3 | $66.82 |
| Pfizer Inc. PFE | 2 | $57.65 |
| Vivus LLC | 3 | $51.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.